Patrick R. O'Neil, EVP CLO & General Counsel at IONIS PHARMACEUTICALS INC (IONS), sold 179,800 shares at $54.51 ($10.8M) on 2025-09-02, disclosed to the SEC on 2025-09-04.
Scheduled sale ($10.8M) by EVP CLO & General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.51 | 13,050 | $711K | 6.6% |
| 2 | $54.51 | 13,050 | $711K | 6.6% |
| 3 | $60.89 | 65,475 | $4.0M | 36.9% |
| 4 | $60.89 | 65,475 | $4.0M | 36.9% |
| 5 | $61.42 | 11,375 | $699K | 6.5% |
| 6 | $61.42 | 11,375 |
| $699K |
| 6.5% |
| Total | $60.03 avg | 179,800 | $10.8M | 100% |
| Filing → |
| IONS | SELL | 2026-02-02 | $516K | — | Filing → |
| IONS | SELL | 2026-01-20 | $697K | — | Filing → |
| IONS | SELL | 2025-10-08 | $1.2M | — | Filing → |